Angel Matthew
Insider CIK 1931356 · TPST CEO and President, Director, 10% owner · BTX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TPST Tempest Therapeutics, Inc. | P Buy deriv | 2026-03-24 | 2026-06-23 | 231,482 | — | $0 | 231,482 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | P Buy deriv | 2026-03-24 | 2026-06-23 | 231,482 | — | $0 | 231,482 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | P Buy | 2026-03-24 | 2026-06-23 | 231,482 | $2.16 | $500.0K | 231,482 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | P Buy | 2026-03-24 | 2026-03-25 | 231,482 | $2.16 | $500.0K | 231,482 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | A Award deriv | 2026-02-04 | 2026-02-06 | 269,621 | — | $0 | 269,621 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | A Award deriv | 2023-01-12 | 2023-01-13 | 132,003 | — | $0 | 132,003 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2022-08-01 | 2022-08-03 | 2,487,003 | — | $0 | 2,487,003 | SEC↗ |